Richard Woodrich
Keine laufenden Positionen mehr
Profil
Richard Woodrrich is Chairman of Statsure Diagnostic Systems, Inc. He has more than 17 years experience in the biopharmaceutical industry.
He was Senior Vice President of Business Development for Therion Biologics Corporation from 1999 to 2004.
He was Chief Operating Officer of Cytomed, Inc. from 1996 to 1999.
He was Chief Financial Officer of Applied Biotechnology from 1986 to 1991.
He graduated from The Harvard Graduate School of Business Administration.
He is a Certified Public Accountant.
Ehemalige bekannte Positionen von Richard Woodrich
| Unternehmen | Position | Ende |
|---|---|---|
| STATSURE DIAGNOSTIC SYSTEMS, INC. | Vorsitzender | 01.07.2008 |
CytoMed, Inc.
 CytoMed, Inc. Pharmaceuticals: MajorHealth Technology Part of Takeda Pharmaceutical Co., Ltd., CytoMed, Inc. is a company that develops therapeutics for cancer treatment. The company is based in Cambridge, MA. CytoMed was acquired by LeukoSite, Inc., part of Takeda Pharmaceutical Co., Ltd. from December 22, 1999 on February 12, 1999 for $19.29 million. | Geschäftsführer | 01.01.2004 |
Therion Biologics Corp.
 Therion Biologics Corp. Pharmaceuticals: MajorHealth Technology Therion Biologics Corp. developed therapeutic vaccines for cancer patients. The company was founded on May 5, 1991 and was headquartered in Cambridge, MA. | Corporate Officer/Principal | 01.01.2004 |
Ausbildung von Richard Woodrich
| Harvard University | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| STATSURE DIAGNOSTIC SYSTEMS, INC. | Health Technology |
| Private Unternehmen | 2 |
|---|---|
CytoMed, Inc.
CytoMed, Inc. Pharmaceuticals: MajorHealth Technology Part of Takeda Pharmaceutical Co., Ltd., CytoMed, Inc. is a company that develops therapeutics for cancer treatment. The company is based in Cambridge, MA. CytoMed was acquired by LeukoSite, Inc., part of Takeda Pharmaceutical Co., Ltd. from December 22, 1999 on February 12, 1999 for $19.29 million. | Health Technology |
Therion Biologics Corp.
Therion Biologics Corp. Pharmaceuticals: MajorHealth Technology Therion Biologics Corp. developed therapeutic vaccines for cancer patients. The company was founded on May 5, 1991 and was headquartered in Cambridge, MA. | Health Technology |
